Sign In
Get Clay Free →

Suggestions

    Andrew Hindman

    Biotech Entrepreneur // Non-Profit Work

    Andrew Hindman is a seasoned biotech executive with a proven track record of establishing companies, enhancing shareholder value, and providing healthcare solutions to patients and caregivers. With close to 30 years of experience, Andrew has been involved in a range of high-value transactions including M&A deals, BD Partnerships, Equity/Debt financings, and Royalty Monetization/securitizations totaling over $30 billion.

    He possesses a strong set of financial, strategic, and operational skills specifically tailored to the drug development and commercialization sector. Andrew holds an MBA in Finance from Columbia Business School, a BA in Biochemistry and Economics from Wesleyan University, and has also completed Executive Education in Leadership and Strategy in Pharma & Biotech at Harvard Business School.

    Throughout his career, Andrew has held pivotal roles in various organizations, including positions such as Biotech Entrepreneur at NewCo, Chief Financial Officer at Theravance Biopharma US, Inc., Chief Business Officer at Acorda Therapeutics, Inc., Board Member at Biotechnology Industry Organization, President and Chief Executive Officer at Tobira Therapeutics, Senior Vice President, Corporate Development at Nodality Inc., Vice President, Corporate Development at Onyx Pharmaceuticals, Senior Director at Gilead Sciences, and Associate-Healthcare Investment Banking at J.P. Morgan.

    His extensive educational background combined with his diverse professional experience has equipped Andrew Hindman with a unique blend of expertise in the biotech industry, making him a valuable asset in driving innovation, growth, and success in the healthcare sector.

    Andrew Hindman
    Add to my network

    Location

    San Francisco, California, United States